NEPHNEPHROS INC

Nasdaq nephros.com


$ 2.23 $ -0.13 (-5.58 %)    

Friday, 03-May-2024 15:57:35 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 2.2
$ 2.23
$ 0.00 x 0
$ 0.00 x 0
$ 2.23 - $ 2.23
$ 1.13 - $ 4.04
14,201
na
22.85M
$ 0.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-15-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-03-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-27-2020 12-31-2019 10-K
18 11-06-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 03-12-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 02-26-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-20-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-08-2016 06-30-2016 10-Q
32 05-11-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-10-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 04-15-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-upgrades-nephros-to-speculative-buy-announces-5-price-target

Benchmark analyst Robert Wasserman upgrades Nephros (NASDAQ:NEPH) from Hold to Speculative Buy and announces $5 price target.

 nephros-q4-earnings-insights
Nephros: Q4 Earnings Insights
03/07/2024 21:45:17

 nephros-q4-2023-gaap-eps-0060-misses-0030-estimate-sales-3300m-miss-3813m-estimate

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.030) b...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 earnings-outlook-for-nephros
Earnings Outlook For Nephros
03/06/2024 18:02:29

 why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

 insiders-buying-delcath-systems-and-3-other-penny-stocks

The Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confi...

 nephros-q3-earnings-insights
Nephros: Q3 Earnings Insights
11/08/2023 21:50:23

 nephros-q3-eps-002-beats-006-estimate-sales-374m-beat-335m-estimate

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.06) by 66...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

 nephros-q2-eps-004-beats-005-estimate-sales-354m-beat-311m-estimate

Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20...

 earnings-scheduled-for-august-9-2023

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on r...

 why-lululemon-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket

Gainers Better Choice Company Inc. (NASDAQ: BTTR) shares rose 37% to $0.4522 in pre-market trading. Better Choice said it h...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION